14
Views
0
CrossRef citations to date
0
Altmetric
Review

How can physicians improve medication adherence and outcomes in dermatological conditions?

, &
Received 31 Jan 2024, Accepted 18 Jun 2024, Published online: 24 Jun 2024

References

  • Walsh CA, Cahir C, Tecklenborg S, et al. The association between medication non-adherence and adverse health outcomes in ageing populations: a systematic review and meta-analysis. Br J Clin Pharmacol. 2019;85(11):2464–2478. doi: 10.1111/bcp.14075
  • Morris LS, Schulz RM. Patient compliance–an overview. J Clin Pharm Ther. 1992;17(5):283–295. doi: 10.1111/j.1365-2710.1992.tb01306.x
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi: 10.1056/NEJMra050100
  • Bonaccorso S, Sturchio JL. What information do patients need about medicines? Perspectives from the pharmaceutical industry. BMJ. 2003;327(7419):863–864. doi: 10.1136/bmj.327.7419.863
  • Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med care. 2005;43(6):517–520. doi: 10.1097/01.mlr.0000166617.68751.5f
  • Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76–87. doi: 10.1111/j.1742-1241.2007.01630.x
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Brit J Clinical Pharma. 2012;73(5):691–7058. doi: 10.1111/j.1365-2125.2012.04167.x
  • Feldman SR, Vrijens B, Gieler U, et al. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol. 2017;18(2):253–271. doi: 10.1007/s40257-017-0253-5
  • Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607–613. doi: 10.1016/j.jaad.2005.12.021
  • Balkrishnan R, Carroll CL, Camacho FT, et al. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol. 2003;49(4):651–654. doi: 10.1067/S0190-9622(03)00912-5
  • Cobo B, Castillo E, López-Torrecillas F, et al. Indirect questioning methods for sensitive survey questions: modelling criminal behaviours among a prison population. PLOS ONE. 2021 Jan 22;16(1):e0245550. doi: 10.1371/journal.pone.0245550
  • Storm A, Benfeldt E, Andersen SE, et al. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59(6):975–980. doi: 10.1016/j.jaad.2008.07.039
  • Bluett J, Riba-Garcia I, Verstappen SMM, et al. Development and validation of a methotrexate adherence assay. Ann Rheum Dis. 2019;78(9):1192–1197. doi: 10.1136/annrheumdis-2019-215446
  • Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150(7):1377–1378. doi: 10.1001/archinte.1990.00390190043003
  • Shah PM, Balogh EA, Van Gorkom AR, et al. Developing electronic monitor adapters for dermatologic medication containers: a methods paper. Skin Res Technol. 2022;28(2):371–373. doi: 10.1111/srt.13124
  • Sensal Health [Internet]. Chapel Hill (NC): Sensal Health. [cited 2024 Jan 8]. Available from: https://www.sensalhealth.com/solutions
  • Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231–236. doi: 10.2165/00128071-200607040-00004
  • Eicher L, Knop M, Aszodi N, et al. A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease – strategies for optimizing treatment outcome. J Eur Acad Dermatol Venereol. 2019;33(12):2253–2263. doi: 10.1111/jdv.15913
  • Alinia H, Moradi Tuchayi S, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176(3):759–764. doi: 10.1111/bjd.15085
  • Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212–216. doi: 10.1016/j.jaad.2004.01.052
  • Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–216. doi: 10.1016/j.jaad.2006.05.073
  • The Federal Register. Federal register: request access. [updated 2024 May 16; cited 2024 May 16]. Available from: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46/subpart-A/section-46.116
  • Levine RJ. Monitoring for adherence: ethical considerations. Am J Respir Crit Care Med. 1994;149(2):287–288. doi: 10.1164/ajrccm.149.2.8306018
  • Office of the Human Research Protection Program [Internet]. Los Angeles (CA): UCLA; [updated 2020 Jul 7; cited 2020 Jul 7]. Available from: https://ora.research.ucla.edu/OHRPP/Documents/Policy/8/Deception.pdf
  • Patel NU, Moore BA, Craver RF, et al. Ethical considerations in adherence research. Patient Prefer Adherence. 2016 Dec 5;10:2429–2435. doi: 10.2147/PPA.S117802
  • Rand CS, Sevick MA. Ethics in adherence promotion and monitoring. Controlled Clinical Trials. 2000;21(5):241S–247S. doi: 10.1016/S0197-2456(00)00085-4
  • Ahn CS, Culp L, Huang WW, et al. Adherence in dermatology. J DermatolTreat. 2017;28(2):94–103. doi: 10.1080/09546634.2016.1181256
  • Price KN, Grinnell M, Butler D, et al. Art of prevention: Practical tips for improving adherence to treatments for older patients in dermatology. Int J Womens Dermatol. 2021 Mar;7(4):478–481. doi: 10.1016/j.ijwd.2021.03.006
  • Tan X, Feldman SR, Chang J, et al. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9(10):1263–1271. doi: 10.1517/17425247.2012.711756
  • Richards HL, Fortune DG, O’Sullivan TM, et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581–583. doi: 10.1016/S0190-9622(99)70301-4
  • Thorneloe RJ, Bundy C, Griffiths CE, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168(1):20–31. doi: 10.1111/bjd.12039
  • Hodari KT, Nanton JR, Carroll CL, et al. Adherence in dermatology: a review of the last 20 years. J Dermatol Treat. 2006;17(3):136–14233. doi: 10.1080/09546630600688515
  • Chan SA, Hussain F, Lawson LG, et al. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J DermatolTreat. 2013;24(1):64–69. doi: 10.3109/09546634.2011.607425
  • Xu C, Teeple A, Wu B, et al. Drug adherence and persistence of patients with moderate to severe psoriasis treated with biologic medications in a US commercially insured population. Dermatology. 2022;238(3):438–447. doi: 10.1159/000519176
  • Alsubeeh NA, Alsharafi AA, Ahamed SS, et al. Treatment adherence among patients with five dermatological diseases and four treatment types - a cross-sectional study. Patient Prefer Adherence. 2019 Dec 3;13:2029–2038. doi: 10.2147/PPA.S230921
  • Yentzer BA, Yelverton CB, Pearce DJ, et al. Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. J Am Acad Dermatol. 2008;59(4):577–581. doi: 10.1016/j.jaad.2008.06.007
  • Choi E, Tan KW, Tang F, et al. Efficacy of targeted education in reducing topical steroid phobia: a randomized clinical trial. J Am Acad Dermatol. 2020;83(6):1681–1687. doi: 10.1016/j.jaad.2020.02.079
  • Patel N, Feldman SR. Management of atopic dermatitis. In: Fortson EA, Feldman SR, Strowd LC, editors. Chapter 12, adherence in atopic dermatitis. Switzerland: Springer International Publishing AG; 2024. p. 139–156.
  • Anderson KL, Dothard EH, Huang KE, et al. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015;151(6):623–626. doi: 10.1001/jamadermatol.2014.5254
  • Yentzer BA, Ade RA, Fountain JM, et al. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis. 2010;86:103–108.
  • Chan WH, Lewis DJ, Duvic M, et al. Strategies to optimize adherence in patients with mycosis fungoides. Cells. 2021 Dec 30;11(1):113. doi: 10.3390/cells11010113
  • Sagransky MJ, Yentzer BA, Williams LL, et al. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146(12):1428–1430. doi: 10.1001/archdermatol.2010.368
  • Yentzer BA, Ade RA, Fountain JM, et al. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010;86:208–213.
  • Davis SA, Feldman SR. An Illustrated dictionary of behavioral economics for healthcare professionals. CreateSpace Indep Publishing Platf. 2014:248.
  • Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, et al. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis [published correction appears in. J Am Acad Dermatol. 2021 Aug;85(83):944–946. doi: 10.1016/j.jaad.2020.01.044
  • Rork JF, Sheehan WJ, Gaffin JM, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–39247. doi: 10.1001/archdermatol.2011.2267
  • Oussedik E, Cardwell LA, Patel NU, et al. An anchoring-based intervention to increase patient willingness to use injectable medication in psoriasis. JAMA Dermatol. 2017;153:932–934.
  • Johnson MC, Oussedik E, Huang WW, et al. Anecdote increases patient willingness to take a biologic medication for psoriasis. Cutis. 2021;108(2S):20–24. doi: 10.12788/cutis.0320
  • Bashyam AM, Cuellar-Barboza A, Masicampo EJ, et al. Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use. J Am Acad Dermatol. 2020;83(6):1773–1775. doi: 10.1016/j.jaad.2020.03.074
  • Warden BA, Freels JP, Furuno JP, et al. Pharmacy-managed program for providing education and discharge instructions for patients with heart failure. Am J Health Syst Pharm. 2014;71(2):134–139. doi: 10.2146/ajhp130103
  • Tuchayi S, Alexander TM, Nadkarni A, et al. Interventions to increase adherence to acne treatment. Patient Prefer Adherence. 2016 Oct 11;10:2091–2096. doi: 10.2147/PPA.S117437
  • Armstrong AW, Idriss NZ, Kim RH. Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: a randomized controlled trial. Patient Educ Couns. 2011;83(2):273–277. doi: 10.1016/j.pec.2010.04.033
  • Sato J, Ishikawa H, Yasuda Y, et al. Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody. J Oncol Pharm Pract. 2020;26(7):1667–1675. doi: 10.1177/1078155220904149
  • Pathak GN, Chandy RJ, Shah R, et al. The pharmacist’s role in dermatology: patient medication adherence. J Dermatol. 2023;50(9):1099–1107. doi: 10.1111/1346-8138.16895
  • Laffer MS, Feldman SR. Improving medication adherence through technology: analyzing the managing meds video challenge. Skin Res Technol. 2014;20(1):62–66. doi: 10.1111/srt.12084
  • Balato N, Megna M, Di Costanzo L, et al. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2013;168(1):201–205. doi: 10.1111/j.1365-2133.2012.11205.x
  • Pena-Robichaux V, Kvedar JC, Watson AJ. Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract. 2010;2010:894258. doi: 10.1155/2010/894258
  • Armstrong AW, Watson AJ, Makredes M, et al. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol. 2009;145(11):1230–1236. doi: 10.1001/archdermatol.2009.269
  • Yentzer BA, Wood AA, Sagransky MJ, et al. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011;147(10):1223–1224. doi: 10.1001/archdermatol.2011.277
  • Storm A, Benfeldt E, Andersen SE, et al. Basic drug information given by physicians is deficient, and patients’ knowledge low. J DermatolTreat. 2009;20(4):190–193. doi: 10.1080/09546630802570818

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.